| For: | Halkjær SI, Lo B, Cold F, Højer Christensen A, Holster S, König J, Brummer RJ, Aroniadis OC, Lahtinen P, Holvoet T, Gluud LL, Petersen AM. Fecal microbiota transplantation for the treatment of irritable bowel syndrome: A systematic review and meta-analysis. World J Gastroenterol 2023; 29(20): 3185-3202 [PMID: 37346153 DOI: 10.3748/wjg.v29.i20.3185] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v29/i20/3185.htm |
| Number | Citing Articles |
| 1 |
Ida Schoultz, Marcus J. Claesson, Maria Gloria Dominguez‐Bello, Frida Fåk Hållenius, Peter Konturek, Katri Korpela, Martin Frederik Laursen, John Penders, H. Roager, Tommi Vatanen, Lena Öhman, Maria C. Jenmalm. Gut microbiota development across the lifespan: Disease links and health‐promoting interventions. Journal of Internal Medicine 2025; 297(6) doi: 10.1111/joim.20089
|
| 2 |
Natsuda Aumpan, Jun Watanabe, Yuhong Yuan, Takeshi Kanno, Grigorios I. Leontiadis, Francis K.L. Chan, Paul Moayyedi. Fecal Microbiota Transplantation for Symptom Improvement in Patients With Irritable Bowel Syndrome: Systematic Review and Meta-Analysis of Randomized Controlled Trials. Gastroenterology 2026; doi: 10.1053/j.gastro.2026.04.039
|
| 3 |
Yunyao Qu, Si Hong Park, David C. Dallas. Evaluating the Potential of Casein Glycomacropeptide in Adult Irritable Bowel Syndrome Management: A Pilot Study. Nutrients 2023; 15(19) doi: 10.3390/nu15194174
|
| 4 |
EFFICACY OF DIETARY, PSYCHOLOGICAL, AND MICROBIOLOGICAL INTERVENTIONS IN IRRITABLE BOWEL SYNDROME (IBS). International Journal of Innovative Technologies in Social Science 2025; 4(4(48)) doi: 10.31435/ijitss.4(48).2025.4134
|
| 5 |
Afnan Ahmed Khan, Israt Jerin Tonni, Md. Shohel Al Faruk, Shormin Akter. Gut Microbiota Modulation in Leptospirosis: Exploring Pathogenic Mechanisms and Novel Therapies. International Journal of Innovative Science and Research Technology 2025; doi: 10.38124/ijisrt/25jul144
|
| 6 |
Lie Zheng, Sheng-Lei Duan, Kai Wang. Research progress concerning the involvement of the intestinal microbiota in the occurrence and development of inflammatory bowel disease. World Journal of Gastroenterology 2025; 31(42): 113170 doi: 10.3748/wjg.v31.i42.113170
|
| 7 |
James L Alexander, Benjamin H Mullish, Linda Thomas, Rinse K Weersma, Harry Sokol, Lauren A Roberts, Lindsey A Edwards, Anton Emmanuel, Konstantinos Gerasimidis, Lindsay J Hall, Tariq H Iqbal, James M Kinross, James McIlroy, Tanya M Monaghan, Chrysi Sergaki, Debbie L Shawcross, Christopher J Stewart, Christopher A Lamb, Horace R T Williams, Richard Hansen, Georgina Hold. Recent advances in our understanding of the gut microbiome: an analysis from the Gut Microbiota for Health Expert Panel of the British Society of Gastroenterology. Gut 2026; doi: 10.1136/gutjnl-2026-338252
|
| 8 |
Sneha Reddy, Savithri C. Veluri. Exploring the Link Between Irritable Bowel Syndrome and Chronic Diseases: A Narrative Overview. Academic Medicine & Surgery 2025; doi: 10.62186/001c.143576
|
| 9 |
Clara M. A. de Bruijn, Anna O. J. Oorthuys, Judith Zeevenhooven, Mark Davids, Johannes H. M. Levels, Arine M. Vlieger, Hilde Herrema, Max Nieuwdorp, Marc A. Benninga. Feasibility and efficacy of fecal microbiota transplantation in adolescents with refractory irritable bowel syndrome: A randomized clinical pilot trial. Journal of Pediatric Gastroenterology and Nutrition 2026; doi: 10.1002/jpn3.70459
|
| 10 |
Magdy El-Salhy, Odd Helge Gilja, Jan Gunnar Hatlebakk. Increasing the transplant dose and repeating faecal microbiota transplantation results in the responses of male patients with IBS reaching those of females. Scandinavian Journal of Gastroenterology 2024; 59(4) doi: 10.1080/00365521.2023.2292479
|
| 11 |
Magdy El-Salhy, Maura Corsetti, Odd Helge Gilja, Sutep Gonlachanvit, Jan Gunnar Hatlebakk, Dag Arne Lihaug Hoff, Perttu Lahtinen, Johan Axel Lunding, Tarek Mazzawi, Tanya M Monaghan, Bodil Ohlsson, Tanisa Patcharatrakul, Yong Sung Kim, Cheol Min Shin. Towards a Standard Protocol for Fecal Microbiota Transplantation in Irritable Bowel Syndrome. Journal of Neurogastroenterology and Motility 2026; 32(2) doi: 10.5056/jnm26011
|
| 12 |
Yuxuan Chen, Shuyan Feng, Ying Li, Chi Zhang, Guanqun Chao, Shuo Zhang. Gut microbiota and intestinal immunity—A crosstalk in irritable bowel syndrome. Immunology 2024; 172(1) doi: 10.1111/imm.13749
|
| 13 |
Benjamin H Mullish, Blair Merrick, Mohammed Nabil Quraishi, Aggie Bak, Christopher A Green, David J Moore, Robert J Porter, Ngozi T Elumogo, Jonathan P Segal, Naveen Sharma, Belinda Marsh, Graziella Kontkowski, Susan E Manzoor, Ailsa L Hart, Christopher Settle, Josbert J Keller, Peter Hawkey, Tariq H Iqbal, Simon D Goldenberg, Horace R T Williams.
The use of faecal microbiota transplant as treatment for recurrent or refractory
Clostridioides difficile
infection and other potential indications: second edition of joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines
. Gut 2024; 73(7) doi: 10.1136/gutjnl-2023-331550
|
| 14 |
Gloria Solano-Aguilar, Sukla Lakshman, Celine Chen, Ethiopia Beshah, Aleksey Molokin, Bryan Vinyard, Harry D. Dawson, Monica Santin-Duran, Gonzalo Bruna, Allen Smith, Joseph F. Urban. Fruit and Vegetable Supplemented-Diet Ameliorates Dextran Sodium Sulfate (DSS)-Induced Colitis by Modulating Host Transcriptome and Gut Metagenome Response. Nutrients 2026; 18(6) doi: 10.3390/nu18060937
|
| 15 |
Amanda Luísa Spiller, Beatriz Gabriela da Costa, Ryan Nunes Yoshio Yoshihara, Enya Julia Zucari Nogueira, Natalia Salvador Castelhano, Andrey Santos, Maiara Brusco De Freitas, Daniéla Oliveira Magro, Ligia Yukie Sassaki. Ultra-Processed Foods, Gut Microbiota, and Inflammatory Bowel Disease: A Critical Review of Emerging Evidence. Nutrients 2025; 17(16) doi: 10.3390/nu17162677
|
| 16 |
Mehdi Karimi, Niyousha Shirsalimi, Zahra Hashempour, Hossein Salehi Omran, Eshagh Sedighi, Farzan Beigi, Masoud Mortezazadeh. Safety and efficacy of fecal microbiota transplantation (FMT) as a modern adjuvant therapy in various diseases and disorders: a comprehensive literature review. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1439176
|
| 17 |
Bruno Bonaz. Unmet needs of drugs for irritable bowel syndrome and inflammatory bowel diseases: interest of vagus nerve stimulation and hypnosis. Inflammopharmacology 2024; 32(2) doi: 10.1007/s10787-024-01446-7
|
| 18 |
Magdy El-Salhy, Odd Helge Gilja, Jan Gunnar Hatlebakk. Factors underlying the long-term efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome. Microbes and Infection 2024; 26(8) doi: 10.1016/j.micinf.2024.105372
|
| 19 |
THE EFFECTIVENESS OF PHARMACOLOGICAL, DIETARY, PSYCHOLOGICAL AND NOVEL TREATMENTS IN IRRITABLE BOWEL SYNDROME. International Journal of Innovative Technologies in Social Science 2025; 4(3(47)) doi: 10.31435/ijitss.3(47).2025.3739
|
| 20 |
Abbas Yadegar, Haggai Bar-Yoseph, Tanya Marie Monaghan, Sepideh Pakpour, Andrea Severino, Ed J. Kuijper, Wiep Klaas Smits, Elisabeth M. Terveer, Sukanya Neupane, Ali Nabavi-Rad, Javad Sadeghi, Giovanni Cammarota, Gianluca Ianiro, Estello Nap-Hill, Dickson Leung, Karen Wong, Dina Kao, Christopher Staley. Fecal microbiota transplantation: current challenges and future landscapes. Clinical Microbiology Reviews 2024; 37(2) doi: 10.1128/cmr.00060-22
|
| 21 |
Prashasti Upreti, Lalchand D. Devhare, Lara Hashim Abdulmageed, Yamjala Ganesh Kumar, Rajesh Kumar, G. Dharmamoorthy. Emerging Paradigms for Antibiotic-Resistant Infections: Beyond the Pill. 2024; doi: 10.1007/978-981-97-5272-0_10
|
| 22 |
Elena Montenegro-Borbolla, Jeanine Wakim El-Khoury, Claire Bertelli, Alain Schoepfer, Benoît Guery, Tatiana Galperine. Resolution of long-term severe irritable bowel syndrome following fecal microbiota transplantation: A case report and microbiota analysis. Gut Microbes Reports 2025; 2(1) doi: 10.1080/29933935.2025.2487905
|
| 23 |
Xuesong Tang, Yingjie Liu, Wenjiang Wu, Xingxing Tao. Commentary: Characterization of gut microbiota and metabolites in individuals with constipation-predominant irritable bowel syndrome. Frontiers in Microbiology 2026; 17 doi: 10.3389/fmicb.2026.1726737
|
| 24 |
Raghunath Singh, Kristoffer Panganiban, Emily Au, Rekha Ravikumar, Sandra Pereira, Thomas D. Prevot, Daniel J. Mueller, Gary Remington, Sri Mahavir Agarwal, Elena F. Verdu, Premysl Bercik, Giada De Palma, Margaret K. Hahn. Human-fecal microbiota transplantation in relation to gut microbiome signatures in animal models for schizophrenia: A scoping review. Asian Journal of Psychiatry 2024; 102 doi: 10.1016/j.ajp.2024.104285
|
| 25 |
Isreal Ayobami Onifade, Oluwatomiwa Jubilee Sunbare-Funto, Chinedu Endurance Mbah, Oluwatosin Akinola Ajibade, Olubukola Monisola Oyawoye, Abdullahi Tunde Aborode, Seto Charles Ogunleye, Abdullahi Jamiu, Basit Bolarinwa, Mosope F. Abanikannda, Zainab Tiamiyu, Abidemi Ruth Idowu, Oluwatobiloba Ige, Opara Julia Kelechi, Jeremiah I. Abok, Eniola A. Lawal, Ibude Jane Aruorivwooghene, Adekunle Fatai Adeoye, Olowo Roqeebah, Emmanuel Akinloye Ojewole, Ridwan Olamilekan Adesola. Faecal microbial transplant. Advances in Biomarker Sciences and Technology 2024; 6 doi: 10.1016/j.abst.2024.02.001
|
| 26 |
Jessica R. Allegretti, Sahil Khanna, Benjamin H. Mullish, Paul Feuerstadt. The Progression of Microbiome Therapeutics for the Management of Gastrointestinal Diseases and Beyond. Gastroenterology 2024; 167(5) doi: 10.1053/j.gastro.2024.05.004
|
| 27 |
Manal M Saleem, Sarah Masood , Maryam M Rahmatullah, Ifrah Ayesha Imdad, Asma Mohammed Aslam Sange, Dina Nasr. Gut Microbiota Dysbiosis and Its Role in the Development of Irritable Bowel Syndrome . Cureus 2025; doi: 10.7759/cureus.83084
|
| 28 |
Michał Karasek, Michał Szyszko, Krzysztof Polański, Sylwia Andrzejczuk, Martyna Kasela, Urszula Kosikowska. Linking Gut Microbiota and Irritable Bowel Syndrome (Ibs): A Review. Advancements of Microbiology 2025; 64(3) doi: 10.2478/am-2025-0012
|
| 29 |
B.H. Mullish, B. Merrick, M.N. Quraishi, A. Bak, C.A. Green, D.J. Moore, R.J. Porter, N.T. Elumogo, J.P. Segal, N. Sharma, B. Marsh, G. Kontkowski, S.E. Manzoor, A.L. Hart, C. Settle, J.J. Keller, P. Hawkey, T.H. Iqbal, S.D. Goldenberg, H.R.T. Williams. The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridioides difficile infection and other potential indications: second edition of joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines. Journal of Hospital Infection 2024; 148 doi: 10.1016/j.jhin.2024.03.001
|
| 30 |
Min Jiang, Yu-Hong Huang, Cong Dai. Fecal microbiota transplantation for irritable bowel syndrome: Current evidence and perspectives. World Journal of Gastroenterology 2024; 30(16): 2179-2183 doi: 10.3748/wjg.v30.i16.2179
|
| 31 |
Olaf F. A. Larsen, Robert J. M. Brummer. Perspective: on the future of fecal microbiota transplantation. Frontiers in Microbiology 2024; 15 doi: 10.3389/fmicb.2024.1449133
|
| 32 |
IRRITABLE BOWEL SYNDROME: THE ROLE OF GUT MICROBIOTA IN ETIOLOGY AND TREATMENT. A LITERATURE REVIEW. International Journal of Innovative Technologies in Social Science 2026; (1(49)) doi: 10.31435/ijitss.1(49).2026.4612
|
| 33 |
Andrew Chang, Janice Oh, Andrea Shin, Megan Oser, Natalie Manitius, Amir Ghaffari, Berkeley N. Limketkai. Similar Symptoms, Distinct Syndromes: Multi-modal Approach to the Patient with an IBD-IBS Overlap. Digestive Diseases and Sciences 2026; 71(3) doi: 10.1007/s10620-025-09473-2
|
| 34 |
Maura Corsetti, Andrea Shin, Brian E. Lacy, Brooks D. Cash, Magnus Simrén, Max J. Schmulson, Xiaohua Hou, Anthony Lembo. Bowel Disorders. Gastroenterology 2026; 170(6) doi: 10.1053/j.gastro.2026.02.003
|
| 35 |
Rohma Ghani, Despoina Chrysostomou, Lauren A Roberts, Madhumitha Pandiaraja, Julian R. Marchesi, Benjamin H. Mullish. Faecal (or intestinal) microbiota transplant: a tool for repairing the gut microbiome. Gut Microbes 2024; 16(1) doi: 10.1080/19490976.2024.2423026
|
| 36 |
Andrea Severino, Ege Tohumcu, Luca Tamai, Pasquale Dargenio, Serena Porcari, Debora Rondinella, Irene Venturini, Marcello Maida, Antonio Gasbarrini, Giovanni Cammarota, Gianluca Ianiro. The microbiome-driven impact of western diet in the development of noncommunicable chronic disorders. Best Practice & Research Clinical Gastroenterology 2024; 72 doi: 10.1016/j.bpg.2024.101923
|
| 37 |
EFFICACY OF FECAL MICROBIOTA TRANSPLANTATION IN TREATING GASTROINTESTINAL DISEASES: A SYSTEMATIC REVIEW OF EVIDENCE IN CDI, UC, IBS, AND CROHN’S DISEASE. International Journal of Innovative Technologies in Social Science 2025; 6(3(47)) doi: 10.31435/ijitss.3(47).2025.3752
|
| 38 |
Narjis Kraimi, Taylor Ross, Julien Pujo, Giada De Palma. The gut microbiome in disorders of gut–brain interaction. Gut Microbes 2024; 16(1) doi: 10.1080/19490976.2024.2360233
|
| 39 |
Monu Pandey, Jayanta Bhattacharyya. Gut Microbiota and Epigenetics in Colorectal Cancer: Implications for Carcinogenesis and Therapeutic Intervention. Epigenomics 2024; 16(6) doi: 10.2217/epi-2023-0382
|
| 40 |
Shiju Chen, Daya Zhang, Da Li, Fan Zeng, Chen Chen, Feihu Bai. Microbiome characterization of patients with Crohn disease and the use of fecal microbiota transplantation: A review. Medicine 2025; 104(4) doi: 10.1097/MD.0000000000041262
|